Publications by authors named "Xavier Sanjuan"

PLoS Med 2020 09 24;17(9):e1003292. Epub 2020 Sep 24.

Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain.

J Immunother Cancer 2020 06;8(1)

Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain

Methods 2020 Apr 30. Epub 2020 Apr 30.

Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, University of Barcelona, L' Hospitalet de Llobregat, Barcelona, Spain. Electronic address:

Int J Cancer 2020 Oct 24;147(8):2303-2315. Epub 2020 Apr 24.

Charité Comprehensive Cancer Center, Berlin, Germany.

Am J Surg Pathol 2020 07;44(7):955-961

Department of Gastroenterology, Barcelona Clinic Hospital.

Inflamm Bowel Dis 2018 11;24(12):2555-2564

Department of General and Digestive Surgery, Colorectal Unit, University Hospital Bellvitge (HUB-IDIBELL)-CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.

Biochim Biophys Acta Mol Basis Dis 2018 09 14;1864(9 Pt B):2992-3000. Epub 2018 Jun 14.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. Electronic address:

Target Oncol 2018 02;13(1):81-87

Sarcoma, Melanoma and Genitourinary Tumors Unit, Institut Català d'Oncologia L'Hospitalet, Avda Gran Via Km 2.7, 08907 L'Hospitalet, Barcelona, Spain.

Clin Cancer Res 2017 Oct 23;23(19):5936-5947. Epub 2017 Jun 23.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Mol Cancer Ther 2017 09 16;16(9):1999-2007. Epub 2017 Jun 16.

Department of Medical Oncology, Catalan Institute of Oncology (ICO), Translational Research Laboratory, ICO-Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.

Int J Cancer 2017 10 3;141(7):1365-1380. Epub 2017 Jul 3.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, CIBERONC, Hospitalet de Llobregat, Spain.

Fam Cancer 2017 Oct;16(4):501-507

Hereditary Cancer Program, Catalan Institute of Oncology (ICO), IDIBELL and CIBERONC, Av. Gran Via de l'Hospitalet, 199-203, 08908, Hospitalet de Llobregat (Barcelona), Spain.

Cancer Lett 2017 02 25;386:196-207. Epub 2016 Nov 25.

Sarcoma Research Group, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain. Electronic address:

Nat Commun 2016 11 2;7:13467. Epub 2016 Nov 2.

Clin Sarcoma Res 2016 29;6:10. Epub 2016 Jun 29.

Pathology Department, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.

Mol Cancer Ther 2016 05 1;15(5):1106-12. Epub 2016 Apr 1.

Translational Research Laboratory, Catalan Insitute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Department of Medical Oncology, Catalan Insitute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Oncotarget 2016 Apr;7(14):17711-25

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

Clin Cancer Res 2015 Oct 12;21(20):4709-18. Epub 2015 Jun 12.

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain. Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain.

J Hepatol 2015 Apr 21;62(4):785-90. Epub 2014 Nov 21.

Molecular Virology, Universitat Pompeu Fabra, Barcelona, Spain. Electronic address:

PLoS One 2014 12;9(9):e106748. Epub 2014 Sep 12.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO) and CIBERESP, Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain.

World J Gastroenterol 2014 Aug;20(30):10591-8

Triana Lobatón, Francisco Rodríguez-Moranta, Jordi Guardiola, Department of Gastroenterology, University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat, 08907 Barcelona, Spain.

Histopathology 2014 Nov;65(5):712-7

Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.

Oncotarget 2014 Aug;5(15):6437-52

Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain.

Clin Gastroenterol Hepatol 2014 Nov 30;12(11):1865-70. Epub 2014 Jun 30.

Department of Gastroenterology, Hospital Universitari de Bellvitge-Institut d'Investigació Biomédica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Mol Oncol 2014 Oct 6;8(7):1290-305. Epub 2014 May 6.

Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, 08908 Catalonia, Spain. Electronic address:

Mol Cancer Res 2014 Sep 14;12(9):1254-66. Epub 2014 May 14.

Translational Research Laboratory,

Nat Commun 2014 Apr 3;5:3608. Epub 2014 Apr 3.

1] Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, 08908 Catalonia, Spain [2] Department of Physiological Sciences II, School of Medicine, University of Barcelona, 08036 Barcelona, Spain [3] Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010 Catalonia, Spain.

Mol Cancer 2014 Mar 5;13:46. Epub 2014 Mar 5.

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

Hum Mol Genet 2014 Jul 5;23(13):3506-12. Epub 2014 Feb 5.

Hereditary Cancer Program and.

Nat Methods 2013 Oct 1;10(10):1021-7. Epub 2013 Sep 1.

1] EMBL/CRG Systems Biology Research Unit, Center for Genomic Regulation, Barcelona, Spain. [2] Pompeu Fabra University, Barcelona, Spain. [3] Institut de Recherche en Immunologie et en Cancérologie, Université de Montréal, Montréal, Canada.

J Med Genet 2013 Aug 24;50(8):552-63. Epub 2013 May 24.

Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

PLoS One 2012 7;7(11):e48877. Epub 2012 Nov 7.

Unit of Biomarkers and Susceptibility (UBS), Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

Inflamm Bowel Dis 2013 Jan;19(1):165-73

Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Neoplasia 2011 Oct;13(10):931-46

Laboratory of Translational Research, Institut Català d'Oncologia-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Clin Cancer Res 2011 Dec 5;17(23):7303-12. Epub 2011 Oct 5.

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology, IDIBELL, and CIBERESP, Barcelona, Spain.

Mol Cancer Res 2010 Nov;8(11):1489-500

Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals-3 Planta Gran via s/n Km. 2, 7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

Virchows Arch 2010 May;456(5):533-41

BIOPAT. Biopatologia Molecular, SL, Grup Assistència, Avda. Diagonal 660, Barcelona, Spain.

Clin Transl Oncol 2010 Mar;12(3):211-3

Pathology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Mol Cancer 2009 Jul 8;8:46. Epub 2009 Jul 8.

Translational Research Laboratory, Institut Català d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

Proc Natl Acad Sci U S A 2009 Apr 26;106(15):6315-20. Epub 2009 Mar 26.

Institut d'Investigació Biomèdica de Bellvitge Gran Via km 2.7, Hospitalet and Institut Municipal d'Investigacions Mèdiques-Hospital del Mar, Dr. Aiguader 88, 08003 Barcelona, Spain.

Cir Esp 2007 Aug;82(2):89-98

Unidad de Cirugía Colorrectal, Servicio de Cirugía General y Digestiva, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Int J Biochem Cell Biol 2004 Nov;36(11):2226-41

Wallenberg Laboratory for Cardiovascular Research, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.

Endocr Pathol 1998 ;9(1):293-300